Chongqing, China

Yunling Wang

This inventor holds 2 USPTO granted patents and 5 published patent applications and 2 EPO patents. Top assignees: Fochon Biosciences, Ltd., Fochon Pharmaceuticals, Ltd.. Active years: 2022-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yunling Wang. Retrieved from https://idiyas.com/inventor/yunling-wang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

 

Average Co-Inventor Count = 10.1

ph-index = 1


Company Filing History:


Years Active: 2022-2023

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Inventor Yunling Wang - Revolutionizing Technology in Chongqing

Introduction: Yunling Wang is a pioneering inventor based in Chongqing, China, known for his groundbreaking contributions to the field of technology.

Latest Patents: Wang's latest patents focus on artificial intelligence applications in robotics, with a particular emphasis on enhancing automation processes in manufacturing industries.

Career Highlights: With over two decades of experience in research and development, Wang has led numerous projects that have resulted in cutting-edge technological solutions. His work has significantly impacted the efficiency and productivity of various sectors.

Collaborations: Wang has collaborated with leading tech companies and research institutions both locally and internationally. His partnerships have led to the successful implementation of innovative technologies in real-world settings.

Conclusion: Inventor Yunling Wang's dedication to pushing the boundaries of technology and his commitment to innovation continue to inspire the next generation of inventors and researchers in Chongqing and beyond.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…